| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0378 |
Hospital observation service, per hour |
3,934 |
2,774 |
$1.60M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,814 |
7,768 |
$1.30M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,191 |
6,403 |
$835K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,486 |
2,210 |
$550K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
7,104 |
6,033 |
$508K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,907 |
7,682 |
$97K |
| 84484 |
|
8,200 |
5,329 |
$85K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
379 |
346 |
$79K |
| 71045 |
Radiologic examination, chest; single view |
6,444 |
5,514 |
$75K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,492 |
3,105 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,901 |
11,395 |
$68K |
| 36415 |
Collection of venous blood by venipuncture |
17,718 |
12,610 |
$61K |
| 80053 |
Comprehensive metabolic panel |
8,011 |
5,827 |
$52K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,092 |
7,296 |
$46K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
601 |
571 |
$33K |
| 81001 |
|
7,319 |
6,428 |
$33K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
565 |
484 |
$29K |
| 84703 |
|
2,190 |
1,962 |
$22K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,449 |
3,528 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,929 |
1,592 |
$19K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,063 |
2,522 |
$18K |
| 82077 |
|
492 |
426 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,618 |
2,068 |
$14K |
| 87400 |
|
264 |
217 |
$14K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,044 |
666 |
$12K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
337 |
280 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
922 |
622 |
$11K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
157 |
145 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,200 |
1,101 |
$10K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,323 |
1,008 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
557 |
515 |
$9K |
| 83690 |
|
2,155 |
1,928 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
916 |
509 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
387 |
343 |
$8K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
222 |
196 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
32 |
28 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
894 |
483 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
192 |
174 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
113 |
107 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
834 |
686 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
151 |
136 |
$4K |
| 80076 |
|
951 |
883 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
32 |
28 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
875 |
725 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
376 |
310 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
447 |
388 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
633 |
497 |
$3K |
| 83735 |
|
2,077 |
1,440 |
$2K |
| 87581 |
|
32 |
28 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
457 |
384 |
$2K |
| 97161 |
|
148 |
126 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
77 |
76 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
387 |
215 |
$2K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
83 |
61 |
$2K |
| 86850 |
|
1,081 |
928 |
$2K |
| 85027 |
|
985 |
661 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
238 |
190 |
$2K |
| 86901 |
|
1,458 |
1,117 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24 |
24 |
$2K |
| 87081 |
|
64 |
59 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
241 |
192 |
$2K |
| 86900 |
|
1,457 |
1,117 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
467 |
433 |
$1K |
| 84600 |
|
73 |
58 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
315 |
198 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
50 |
37 |
$1K |
| 80061 |
Lipid panel |
391 |
342 |
$1K |
| 87430 |
|
61 |
59 |
$1K |
| 99201 |
|
14 |
12 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
47 |
44 |
$1K |
| 90686 |
|
51 |
46 |
$919.48 |
| 72100 |
|
38 |
37 |
$762.78 |
| 85610 |
|
952 |
762 |
$758.61 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
131 |
108 |
$737.25 |
| 84443 |
Thyroid stimulating hormone (TSH) |
633 |
581 |
$718.36 |
| 97165 |
|
49 |
40 |
$716.00 |
| 87040 |
|
75 |
40 |
$561.14 |
| 83605 |
|
203 |
154 |
$559.46 |
| 82553 |
|
143 |
93 |
$511.66 |
| 94799 |
|
317 |
49 |
$495.93 |
| 84702 |
|
12 |
12 |
$390.44 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
86 |
69 |
$337.23 |
| 83880 |
|
162 |
143 |
$317.59 |
| 82550 |
|
204 |
139 |
$253.39 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
15 |
13 |
$240.52 |
| 87186 |
|
51 |
49 |
$239.95 |
| 85730 |
|
183 |
152 |
$218.92 |
| 81003 |
|
41 |
38 |
$127.68 |
| 84100 |
|
629 |
483 |
$115.07 |
| 86923 |
|
64 |
50 |
$37.03 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
19 |
17 |
$0.07 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
17 |
15 |
$0.01 |
| 82248 |
|
88 |
63 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
33 |
26 |
$0.00 |
| 0250 |
|
65 |
51 |
$0.00 |
| 87077 |
|
13 |
13 |
$0.00 |
| 87486 |
|
19 |
16 |
$0.00 |